Chin Yang Chemical Corp.

As of June 30, 2026, Chin Yang Chemical Corp. carries a market capitalization of 35.23B, placing it among publicly traded companies globally. Its enterprise value stands at 32.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Chin Yang Chemical Corp. has 21.20M shares outstanding.

As of June 30, 2026, Chin Yang Chemical Corp. trades at a trailing price-to-earnings ratio of 19.78. The price-to-sales ratio is 1.84, and the price-to-book ratio stands at 0.89.

As of June 30, 2026, Chin Yang Chemical Corp. trades at an EV/EBITDA multiple of 23.87 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.71 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 32.54B versus a market cap of 35.23B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Chin Yang Chemical Corp. maintains a current ratio of 1.89, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.31, indicating conservative leverage, while an interest coverage ratio of 1.22 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Chin Yang Chemical Corp. posted a return on equity (ROE) of 4.58, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.80, measuring how efficiently the asset base is converted into earnings. The company generates approximately 496.32M in revenue per employee across its workforce of 38.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 17.84 indicates how many times Chin Yang Chemical Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Chin Yang Chemical Corp. recorded an income tax benefit of -24.36M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 1.74B, leaving 1.77B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Chin Yang Chemical Corp.'s stock has declined approximately 31.89% over the past 52 weeks. The 50-day moving average sits at 1,453.76, while the 200-day moving average is 1,896.51.

Over the twelve months ended June 30, 2026, Chin Yang Chemical Corp. generated 18.98B in revenue and converted that into 1.77B in net income, yielding earnings per share of 84.04. EBITDA reached 1.36B, while operating income came in at -536.40M.

As of June 30, 2026, Chin Yang Chemical Corp. holds 2.82B in cash and equivalents against 120.37M in total debt, resulting in a net debt position of -1.55B. Total book value stands at 39.44B, with working capital of 3.09B providing operational flexibility.

Chin Yang Chemical Corp. produced -609.17M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.65M in capital expenditures, free cash flow totaled -613.82M - equivalent to -29.20 per share.

Over the twelve months ended June 30, 2026, Chin Yang Chemical Corp. posted a gross margin of 9.63, reflecting its pricing power and cost economics. The operating margin of -2.83 and net profit margin of 9.31 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -1.76: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 99.35, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Chin Yang Chemical Corp. shareholders.

Chin Yang Chemical Corp.'s most recent stock split took place on September 19, 2024 with a 494:543 split ratio.

As of June 30, 2026, Chin Yang Chemical Corp. has an Altman Z-Score of 3.82, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.